Barely Significant
← all excerpts

Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells.

Oncotarget · 2015 · PMC4467148 · PMID 25779659

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

highly significantP < 0.01actually significant
Differences were considered to be significant for P < 0.05 and highly significant for P < 0.01 and P < 0.001.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.